RBC Capital Maintains Sector Perform on Amgen, Raises Price Target to $256
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza has maintained a 'Sector Perform' rating on Amgen (NASDAQ:AMGN) and raised the price target from $253 to $256.
November 01, 2023 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amgen's price target has been raised from $253 to $256 by RBC Capital, maintaining a 'Sector Perform' rating.
The news of RBC Capital raising the price target for Amgen while maintaining a 'Sector Perform' rating is directly related to the company. However, as the change in price target is minimal, it may not have a significant impact on the stock's short-term price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100